ReviewCells2022

Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple Sclerosis.

Danica Nheu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.